Could your patient's symptoms be masking aPAP?
Autoimmune pulmonary alveolar proteinosis (aPAP) is a rare lung disease that presents with nonspecific pulmonary symptoms, allowing it to hide behind a diagnosis of more common pulmonary illnesses.1,2
Savara Inc. has launched the aPAP ClearPath™ Testing Program with the goal of improving the understanding of the signs and symptoms of rare respiratory diseases, including pulmonary alveolar proteinosis (PAP), and educating physicians about the clinical benefits of early testing as a diagnostic tool to confirm or rule out autoimmune PAP (aPAP).